Potential Biomarkers for Neurobrucellosis Diagnosis and Treatment Based on Cerebrospinal Fluid Metabolomics Analysis
Rapid Communications in Mass Spectrometry · 2025
DOI: 10.1002/rcm.9946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, 2025. Verfasst von Meiling Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China. Hauptthemen laut MEDLINE: Biomarkers, Metabolomics, Brucellosis. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Inner Mongolia Department of Science and Technology, Science and Technology Plan Project, Exploring the Mechanism of Oxidative Damage Caused by Brucella Infect…, Inner Mongolia Medical University, General Project, Metabolomics Based on Quinolinic Acid Regulation for the Mechanism of Brucellosis Microglial Damage, Inner Mongolia Autonomous Region Health Science and Technology Program Project, Research on the Related Mechanisms of Microglial Cell Damage in Brucellosis Bas….
Abstract (Originalsprache)
Background
Zhenzhu Tongluo pills (ZZTL) have been utilized for the treatment of neurobrucellosis (NB) in the Inner Mongolia region of China. However, the specific mechanism underlying the neuroprotective effects of ZZTL in NB remains insufficiently explored. Therefore, this study aimed to analyze the metabolite profiles across different groups to identify potential biomarkers for the diagnosis and treatment of NB.
Methods
LC–MS analysis was used to screen differential metabolites in cerebrospinal fluid (CSF) samples from control subjects, NB patients, and NB patients undergoing ZZTL therapy.
Results
We identified 225 common metabolites across two comparison groups (NB vs. control group and NB + ZZTL vs. NB group). Among these metabolites, 138 were downregulated, and 87 were upregulated in the NB group compared to the control group, while the levels of these metabolites were reversed by ZZTL therapy. Creatinine exhibited the highest VIP score in both comparison groups, with elevated levels observed in CSF samples from NB patients compared to controls; however, its levels were reduced following ZZTL therapy. Additionally, hypoxanthine and uric acids levels were also increased in CSF samples from NB patients, indicating dysregulation of purine metabolism in NB; however, these changes were reversed by ZZTL. Furthermore, pantothenic acid (vitamin B5) and niacinamide (vitamin B3) levels were decreased in CSF samples from NB patients, suggesting a potential link between NB and vitamin B3 and B5 deficiency; however, these changes were reversed by ZZTL.
Conclusion
Collectively, CSF metabolomics may effectively differentiate NB patients from control subjects, providing valuable insights for NB diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
- Department of Radiation Oncology, Inner Mongolia Cancer Hospital & Affiliated People's Hospital of Inner Mongolia Medical University, Hohhot, China.
ORCID-Profile: Zhelin Zhang
Förderung
- Inner Mongolia Department of Science and Technology, Science and Technology Plan Project, Exploring the Mechanism of Oxidative Damage Caused by Brucella Infect…
- Inner Mongolia Medical University, General Project, Metabolomics Based on Quinolinic Acid Regulation for the Mechanism of Brucellosis Microglial Damage
- Inner Mongolia Autonomous Region Health Science and Technology Program Project, Research on the Related Mechanisms of Microglial Cell Damage in Brucellosis Bas…
- Inner Mongolia Natural Science Foundation Committee, Exploring the Mechanism of Oxidative Damage Caused by Brucella Infection in Neuronal Cells Based on Multi…
Zitieren
APA
Liu, M., Shi, S., Guo, Y., Lv, M., Feng, X., Liu, T., Yang, H., & Zhang, Z. (2025). Potential Biomarkers for Neurobrucellosis Diagnosis and Treatment Based on Cerebrospinal Fluid Metabolomics Analysis. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.9946
Vancouver
Liu M, Shi S, Guo Y, Lv M, Feng X, Liu T, et al. Potential Biomarkers for Neurobrucellosis Diagnosis and Treatment Based on Cerebrospinal Fluid Metabolomics Analysis. Rapid Communications in Mass Spectrometry. 2025. doi:10.1002/rcm.9946
BibTeX
@article{Liu2025,
author = {Liu, Meiling and Shi, Shujun and Guo, Yuzhou and Lv, Menghan and Feng, Xuan and Liu, Ting and Yang, Hao and Zhang, Zhelin},
title = {Potential Biomarkers for Neurobrucellosis Diagnosis and Treatment Based on Cerebrospinal Fluid Metabolomics Analysis},
journal = {Rapid Communications in Mass Spectrometry},
year = {2025},
doi = {10.1002/rcm.9946}
}
EUVIMED